Template:Trichomonas antibiotics: Difference between revisions
| (4 intermediate revisions by 3 users not shown) | |||
| Line 4: | Line 4: | ||
====Pregnant==== | ====Pregnant==== | ||
''Only treat if the patient is symptomatic | ''Only treat if the patient is symptomatic'' | ||
*[[Metronidazole]] | *[[Metronidazole]] 500mg PO BID for 7 days <ref>CDC Trichomoniasis 2021. https://www.cdc.gov/std/treatment-guidelines/trichomoniasis.htm</ref> | ||
====Sexual Partner Treatment==== | ====Sexual Partner Treatment==== | ||
* | *Female: Same as above | ||
*Male: [[Metronidazole]] 2 gm PO x1 <ref>Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon </ref> | |||
*[[Metronidazole]] | |||
Latest revision as of 03:03, 26 December 2024
Non-Pregnant
- Metronidazole 500mg PO BID for 7 days [1]
- Tinidazole 2g PO once
Pregnant
Only treat if the patient is symptomatic
- Metronidazole 500mg PO BID for 7 days [2]
Sexual Partner Treatment
- Female: Same as above
- Male: Metronidazole 2 gm PO x1 [3]
- ↑ Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon
- ↑ CDC Trichomoniasis 2021. https://www.cdc.gov/std/treatment-guidelines/trichomoniasis.htm
- ↑ Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon